112 related articles for article (PubMed ID: 1936899)
21. Contrasting tissue factors predict heterogeneous striatal dopamine neurotoxicity after MPTP or methamphetamine treatment.
Marshall JF; Navarrete RJ
Brain Res; 1990 Nov; 534(1-2):348-51. PubMed ID: 2073599
[TBL] [Abstract][Full Text] [Related]
22. Protocatechuic acid inhibits neurotoxicity induced by MPTP in vivo.
Zhang HN; An CN; Zhang HN; Pu XP
Neurosci Lett; 2010 Apr; 474(2):99-103. PubMed ID: 20227465
[TBL] [Abstract][Full Text] [Related]
23. Manganese does not alter the severe neurotoxicity of MPTP.
Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y
Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923
[TBL] [Abstract][Full Text] [Related]
24. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
Przedborski S; Jackson-Lewis V; Yokoyama R; Shibata T; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 1996 May; 93(10):4565-71. PubMed ID: 8643444
[TBL] [Abstract][Full Text] [Related]
25. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP].
Averkin RG; Korshunov VA; Shchegolevskiĭ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS
Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690
[TBL] [Abstract][Full Text] [Related]
26. Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice.
Kirchhoff J; Mørk A; Brennum LT; Sager TN
Neuroreport; 2009 Mar; 20(5):482-6. PubMed ID: 19262413
[TBL] [Abstract][Full Text] [Related]
27. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl.
Saitoh T
J Neurol Sci; 1988 Feb; 83(2-3):161-6. PubMed ID: 3258627
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke.
Carr LA; Rowell PP
Neuropharmacology; 1990 Mar; 29(3):311-4. PubMed ID: 2325834
[TBL] [Abstract][Full Text] [Related]
29. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.
Oeckl P; Ferger B
Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149
[TBL] [Abstract][Full Text] [Related]
30. Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
Dluzen D; Jain R; Liu B
J Neurochem; 1994 Jan; 62(1):94-101. PubMed ID: 8263548
[TBL] [Abstract][Full Text] [Related]
31. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T
Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265
[TBL] [Abstract][Full Text] [Related]
32. Intrastriatal injection of 5,7-dihydroxytryptamine decreased 5-HT levels in the striatum and suppressed locomotor activity in C57BL/6 mice.
Chia LG; Ni DR; Cheng FC; Ho YP; Kuo JS
Neurochem Res; 1999 Jun; 24(6):719-22. PubMed ID: 10447454
[TBL] [Abstract][Full Text] [Related]
33. Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice.
Ookubo M; Yokoyama H; Kato H; Araki T
Mol Cell Endocrinol; 2009 Nov; 311(1-2):62-8. PubMed ID: 19631714
[TBL] [Abstract][Full Text] [Related]
34. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice.
Mizukawa K; Ogawa N; Sora YH
Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):121-8. PubMed ID: 3258432
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effects of (+/-)-catechin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mice.
Ruan H; Yang Y; Zhu X; Wang X; Chen R
Neurosci Lett; 2009 Jan; 450(2):152-7. PubMed ID: 19070648
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
[TBL] [Abstract][Full Text] [Related]
37. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
[TBL] [Abstract][Full Text] [Related]
38. Enhanced MPTP neurotoxicity after treatment with isoflurophate or cholinergic agonists.
Hadjiconstantinou M; Hubble JP; Wemlinger TA; Neff NH
J Pharmacol Exp Ther; 1994 Aug; 270(2):639-44. PubMed ID: 7915317
[TBL] [Abstract][Full Text] [Related]
39. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T
Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240
[TBL] [Abstract][Full Text] [Related]
40. Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson's disease.
Barbiero JK; Santiago RM; Lima MM; Ariza D; Morais LH; Andreatini R; Vital MA
Behav Brain Res; 2011 Jan; 216(1):186-92. PubMed ID: 20688106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
